MIM to Present at CJS Securities Annual New Ideas for the New Year Conference
MIM to Present at CJS Securities Annual New Ideas for the New Year Conference
January 7, 2003 at 10:31 AM EST
ELMSFORD, N.Y.--(BUSINESS WIRE)--Jan. 7, 2003--MIM Corporation
(NASDAQ: MIMS) (CBOE:OQX) (AMEX:OQX), a pharmaceutical healthcare
organization, today announced that it will present at the CJS
Securities Annual New Ideas for the New Year Conference on January 8.
MIM Chairman and Chief Executive Officer Richard H. Friedman, Chief Financial Officer James S. Lusk and President and Chief Operating Officer Alfred Carfora will present at 1:15 PM ET.
Investors may access the slide presentation on the MIM Corporation website, www.mimcorporation.com, under presentations in the investor information section.
MIM Corporation (www.mimcorporation.com) is a pharmaceutical healthcare organization delivering innovative pharmacy benefit and healthcare solutions that provide results beyond expectations. We excel by harnessing our clinical expertise, sophisticated data management, and therapeutic fulfillment capability, and combine it with our dedicated, responsive team of professionals that understands our partners' needs. The result is cost-effective solutions enhancing the quality of patient life.
This press release may contain statements which constitute forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the intent, belief or current expectations of the Company, its directors, or its officers with respect to the future operating performance of the Company. Investors are cautioned that any such forward looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward looking statements as a result of various factors. Important factors that could cause such differences are described in the Company's periodic filings with the Securities and Exchange Commission.
MIM Chairman and Chief Executive Officer Richard H. Friedman, Chief Financial Officer James S. Lusk and President and Chief Operating Officer Alfred Carfora will present at 1:15 PM ET.
Investors may access the slide presentation on the MIM Corporation website, www.mimcorporation.com, under presentations in the investor information section.
MIM Corporation (www.mimcorporation.com) is a pharmaceutical healthcare organization delivering innovative pharmacy benefit and healthcare solutions that provide results beyond expectations. We excel by harnessing our clinical expertise, sophisticated data management, and therapeutic fulfillment capability, and combine it with our dedicated, responsive team of professionals that understands our partners' needs. The result is cost-effective solutions enhancing the quality of patient life.
This press release may contain statements which constitute forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the intent, belief or current expectations of the Company, its directors, or its officers with respect to the future operating performance of the Company. Investors are cautioned that any such forward looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward looking statements as a result of various factors. Important factors that could cause such differences are described in the Company's periodic filings with the Securities and Exchange Commission.
--30--NF/ny
CONTACT: MIM Corporation
James S. Lusk, 914/460-1648
Email: jlusk@mimcorporation.com
or
The Anne McBride Co.
Investor Relations:
Rachel Levine, 212/983-1702
Email: rlevine@annemcbride.com
KEYWORD: NEW YORK
INDUSTRY KEYWORD: PHARMACEUTICAL MEDICAL
SOURCE: MIM Corporation